Search research articles
Contact Us
Filters
Showing results (171-180 of 303) with videos related to
Page
of 31
Sort By:
Journal of Comparative Effectiveness Research
|
October 25, 2021
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy
Perry B Shieh, Gary Elfring, Panayiota Trifillis, et al.
Neuromuscular Disorders : NMD
|
April 28, 2018
Comprehensive nutritional and metabolic assessment in patients with spinal muscular atrophy: Opportunity for an individualized approach
Enid E Martinez, Nicolle Quinn, Kayla Arouchon, et al.
Neuromuscular Disorders : NMD
|
January 22, 2002
Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profile
C G Bönnemann, J Wong, K J Jones, et al.
Journal of Neuromuscular Diseases
|
February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1
Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Muscle & Nerve
|
April 6, 2022
Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States
Basil T Darras, Sabrina Guye, Janine Hoffart, et al.
Plos One
|
March 15, 2019
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
Scott L Lipnick, Denis M Agniel, Rahul Aggarwal, et al.
Annals of Neurology
|
February 28, 2017
Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy
Craig M Zaidman, Jim S Wu, Kush Kapur, et al.
Journal of Neuromuscular Diseases
|
September 4, 2023
Erratum to: Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment
Katlyn E McGrattan, Richard D Shell, Rebecca Hurst-Davis, et al.
Journal of Neuromuscular Diseases
|
April 24, 2023
Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment
Katlyn E McGrattan, Richard D Shell, Rebecca Hurst-Davis, et al.
American Journal of Human Genetics
|
March 1, 1987
Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions
U Francke, J F Harper, B T Darras, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 303) with videos related to
Sort By:
Page
of 31
Journal of Comparative Effectiveness Research
|
October 25, 2021
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy
Perry B Shieh, Gary Elfring, Panayiota Trifillis, et al.
Neuromuscular Disorders : NMD
|
April 28, 2018
Comprehensive nutritional and metabolic assessment in patients with spinal muscular atrophy: Opportunity for an individualized approach
Enid E Martinez, Nicolle Quinn, Kayla Arouchon, et al.
Neuromuscular Disorders : NMD
|
January 22, 2002
Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profile
C G Bönnemann, J Wong, K J Jones, et al.
Journal of Neuromuscular Diseases
|
February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1
Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Muscle & Nerve
|
April 6, 2022
Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States
Basil T Darras, Sabrina Guye, Janine Hoffart, et al.
Plos One
|
March 15, 2019
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
Scott L Lipnick, Denis M Agniel, Rahul Aggarwal, et al.
Annals of Neurology
|
February 28, 2017
Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy
Craig M Zaidman, Jim S Wu, Kush Kapur, et al.
Journal of Neuromuscular Diseases
|
September 4, 2023
Erratum to: Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment
Katlyn E McGrattan, Richard D Shell, Rebecca Hurst-Davis, et al.
Journal of Neuromuscular Diseases
|
April 24, 2023
Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment
Katlyn E McGrattan, Richard D Shell, Rebecca Hurst-Davis, et al.
American Journal of Human Genetics
|
March 1, 1987
Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions
U Francke, J F Harper, B T Darras, et al.
Page
of 31